DE60021068D1 - Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker - Google Patents
Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarkerInfo
- Publication number
- DE60021068D1 DE60021068D1 DE60021068T DE60021068T DE60021068D1 DE 60021068 D1 DE60021068 D1 DE 60021068D1 DE 60021068 T DE60021068 T DE 60021068T DE 60021068 T DE60021068 T DE 60021068T DE 60021068 D1 DE60021068 D1 DE 60021068D1
- Authority
- DE
- Germany
- Prior art keywords
- timp
- matrix metal
- cancer marker
- tissue inhibitor
- metal proteinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900476 | 1999-04-09 | ||
DK990476 | 1999-04-09 | ||
PCT/DK2000/000170 WO2000062070A2 (en) | 1999-04-09 | 2000-04-10 | Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60021068D1 true DE60021068D1 (de) | 2005-08-04 |
DE60021068T2 DE60021068T2 (de) | 2006-05-18 |
Family
ID=8093987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60021068T Expired - Lifetime DE60021068T2 (de) | 1999-04-09 | 2000-04-10 | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker |
Country Status (11)
Country | Link |
---|---|
US (6) | US7108983B1 (de) |
EP (2) | EP1171771B1 (de) |
JP (2) | JP4638608B2 (de) |
AT (1) | ATE298890T1 (de) |
AU (1) | AU771309B2 (de) |
CA (2) | CA2652131A1 (de) |
DE (1) | DE60021068T2 (de) |
ES (1) | ES2244417T3 (de) |
NO (1) | NO329725B1 (de) |
NZ (1) | NZ515311A (de) |
WO (1) | WO2000062070A2 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060154245A1 (en) * | 1999-04-09 | 2006-07-13 | Rigshospitalet | Method for detecting, screening and/or montoring a cancer in individual |
DE60021068T2 (de) | 1999-04-09 | 2006-05-18 | Rigshospitalet | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker |
US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
CA2445168A1 (en) | 2001-04-24 | 2002-10-31 | Bayer Corporation | Human timp-1 antibodies |
AU2003226925A1 (en) * | 2002-04-08 | 2003-10-27 | Hvidovre Hospital | Timp-1 as a postoperative marker for recurrent cancer |
US20060014224A1 (en) * | 2002-09-26 | 2006-01-19 | Hvidovre Hospital | Method for detecting, screening and/or monitoring a cancer in an individual |
CA2526878A1 (en) * | 2003-04-08 | 2004-10-21 | Colotech A/S | A method for detection of colorectal cancer in human samples |
CN1972703A (zh) * | 2004-03-30 | 2007-05-30 | 丹麦皇家兽医和农业学院 | 通过阻断和检测蛋白酶抑制剂改进癌症的治疗和癌症治疗效率的预测 |
US20100196889A1 (en) * | 2006-11-13 | 2010-08-05 | Bankaitis-Davis Danute M | Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
WO2008103815A2 (en) * | 2007-02-23 | 2008-08-28 | Predictive Biosciences Corporation | Clinical intervention directed diagnostic methods |
CN101680898A (zh) * | 2007-05-10 | 2010-03-24 | 霍夫曼-拉罗奇有限公司 | Timp-1作为结肠直肠癌标志的用途 |
WO2009019368A2 (fr) * | 2007-07-19 | 2009-02-12 | bioMérieux | Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal |
FR2919065B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal |
FR2919061B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal. |
FR2919060B1 (fr) | 2007-07-19 | 2012-11-30 | Biomerieux Sa | Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal. |
FR2919064B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal |
FR2919062B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal. |
FR2919063B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal. |
EP2238455A4 (de) * | 2008-01-18 | 2011-03-02 | Vatrix Medical Inc | Diagnostische biomarker für gefässaneurysma |
US8697384B2 (en) | 2008-01-23 | 2014-04-15 | Herlev Hospital | YKL-40 as a general marker for non-specific disease |
JP2011523067A (ja) * | 2008-06-11 | 2011-08-04 | アーゲ ブルナー,ニルス | ネオアジュバントおよびアジュバント全身性抗癌治療のための結腸直腸癌患者の選択 |
FR2933773B1 (fr) | 2008-07-10 | 2013-02-15 | Biomerieux Sa | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal |
US8580520B2 (en) | 2008-09-15 | 2013-11-12 | Herlev Hospital | YKL-40 as a marker for gastrointestinal cancers |
DE102009015784A1 (de) * | 2009-03-31 | 2010-12-02 | Siemens Aktiengesellschaft | In-vitro-Verfahren zur Diagnostik von Tumorerkrankungen |
US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
JP6182308B2 (ja) * | 2012-11-13 | 2017-08-16 | 株式会社エイアンドティー | 前立腺癌の鑑別診断に用いるための泳動波形データの処理方法 |
US9689874B2 (en) | 2015-04-10 | 2017-06-27 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
US20210148894A1 (en) * | 2018-04-13 | 2021-05-20 | Bionomics Limited | Method of monitoring response to a treatment |
WO2021039616A1 (ja) * | 2019-08-23 | 2021-03-04 | 大日本住友製薬株式会社 | 併用療法及びその有効性を示すバイオマーカー |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US62070A (en) * | 1867-02-12 | And jeremiah kimbrough | ||
US111359A (en) * | 1871-01-31 | Improvement in sewing-machines | ||
US234776A (en) * | 1880-11-23 | Belt-coupling | ||
US2086085A (en) * | 1935-05-14 | 1937-07-06 | Handley Page Ltd | Aircraft control gear |
US3087830A (en) * | 1958-12-17 | 1963-04-30 | Schuller Werner Hugo Wilhelm | Method and apparatus for producing a dry mat sheet |
US3006671A (en) * | 1959-08-03 | 1961-10-31 | Gen Precision Inc | Internal staking |
US6271352B1 (en) * | 1985-07-12 | 2001-08-07 | Fonden Til Fremme Af Eksperimentel Cancerforskning | PAI-1 determination and use thereof |
US5356817A (en) * | 1988-06-09 | 1994-10-18 | Yale University | Methods for detecting the onset, progression and regression of gynecologic cancers |
FR2657700A1 (fr) | 1990-01-26 | 1991-08-02 | Thomson Csf | Modulateur electrooptique spatial et applications. |
US5324634A (en) | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
JPH0813654A (ja) | 1994-07-01 | 1996-01-16 | Sekisui House Ltd | 断熱壁下地パネルの施工構造 |
US5569458A (en) * | 1994-09-14 | 1996-10-29 | Greenberg; Mike | Nutritional formula |
JPH08136548A (ja) * | 1994-11-11 | 1996-05-31 | Morinaga & Co Ltd | 泌尿器癌の診断法 |
JP2864219B2 (ja) * | 1995-02-20 | 1999-03-03 | 富士薬品工業株式会社 | 遊離の活性型マトリックスメタロプロテアーゼ類の分別定量法 |
US5643752A (en) * | 1996-01-18 | 1997-07-01 | Incyte Pharmaceuticals, Inc. | Tissue inhibitor of metalloproteinases |
GB9607287D0 (en) * | 1996-04-09 | 1996-06-12 | British Biotech Pharm | Diagnosis method |
JPH10287700A (ja) * | 1997-04-10 | 1998-10-27 | Fuji Yakuhin Kogyo Kk | 活性型マトリライシン(mmp−7)に対する抗体及びそれを用いた免疫学的測定法 |
US5906811A (en) * | 1997-06-27 | 1999-05-25 | Thione International, Inc. | Intra-oral antioxidant preparations |
CN1236102A (zh) | 1998-05-20 | 1999-11-24 | 徐国光 | 唾液癌胚抗原快速检测试剂 |
JP2002526772A (ja) | 1998-10-08 | 2002-08-20 | カルバイオケム ノババイオケム コーポレイション | マトリックスメタロプロテイナーゼ9の診断アッセイおよびその使用 |
DE60021068T2 (de) * | 1999-04-09 | 2006-05-18 | Rigshospitalet | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker |
US20060154245A1 (en) * | 1999-04-09 | 2006-07-13 | Rigshospitalet | Method for detecting, screening and/or montoring a cancer in individual |
US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
US6630163B1 (en) * | 1999-04-22 | 2003-10-07 | Howard Murad | Method of treating dermatological disorders with fruit extracts |
CN1318849C (zh) | 1999-08-06 | 2007-05-30 | Imi国际医学创新股份有限公司 | 以颜色为基础的生化和免疫分析中的光谱测量 |
US7306643B2 (en) * | 2000-01-10 | 2007-12-11 | Sulzer Chemtech Ag | Method for introducing additives to liquid metal, ceramic/metallic powder |
AU1169702A (en) | 2000-10-13 | 2002-04-22 | Childrens Medical Center | Non-invasive enzyme screen for tissue remodelling-associated conditions |
WO2002034776A2 (en) | 2000-10-26 | 2002-05-02 | K.U.Leuven Research And Development | Epitopes of pai-1 |
KR20030067696A (ko) | 2000-11-30 | 2003-08-14 | 모렉큐랄 스킨케어 리미티드 | 질병의 진단 및 치료 |
CA2445168A1 (en) | 2001-04-24 | 2002-10-31 | Bayer Corporation | Human timp-1 antibodies |
US6815181B2 (en) | 2001-07-09 | 2004-11-09 | Applera Corporation | Nucleic acid molecules encoding human secreted hemopexin-related proteins |
CA2453810A1 (en) * | 2001-07-18 | 2003-07-03 | American Red Cross | Mutant proteinase inhibitors and uses thereof |
KR100475642B1 (ko) | 2001-12-29 | 2005-03-10 | 한국생명공학연구원 | 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트 |
AU2003226925A1 (en) | 2002-04-08 | 2003-10-27 | Hvidovre Hospital | Timp-1 as a postoperative marker for recurrent cancer |
EP1382969A1 (de) | 2002-07-17 | 2004-01-21 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diagnose und Behandlung der Invasion von Krebszellen |
US20060014224A1 (en) * | 2002-09-26 | 2006-01-19 | Hvidovre Hospital | Method for detecting, screening and/or monitoring a cancer in an individual |
US20040157278A1 (en) | 2002-12-13 | 2004-08-12 | Bayer Corporation | Detection methods using TIMP 1 |
EP1649064B1 (de) | 2003-07-17 | 2011-06-01 | Pacific Edge Biotechnology Limited | Marker zum nachweis von magenkrebs |
CN1972703A (zh) * | 2004-03-30 | 2007-05-30 | 丹麦皇家兽医和农业学院 | 通过阻断和检测蛋白酶抑制剂改进癌症的治疗和癌症治疗效率的预测 |
-
2000
- 2000-04-10 DE DE60021068T patent/DE60021068T2/de not_active Expired - Lifetime
- 2000-04-10 AU AU36556/00A patent/AU771309B2/en not_active Ceased
- 2000-04-10 NZ NZ515311A patent/NZ515311A/xx not_active IP Right Cessation
- 2000-04-10 CA CA002652131A patent/CA2652131A1/en not_active Abandoned
- 2000-04-10 CA CA002366682A patent/CA2366682C/en not_active Expired - Fee Related
- 2000-04-10 AT AT00915142T patent/ATE298890T1/de not_active IP Right Cessation
- 2000-04-10 JP JP2000611082A patent/JP4638608B2/ja not_active Expired - Fee Related
- 2000-04-10 EP EP00915142A patent/EP1171771B1/de not_active Expired - Lifetime
- 2000-04-10 EP EP05013914A patent/EP1619206A3/de not_active Withdrawn
- 2000-04-10 WO PCT/DK2000/000170 patent/WO2000062070A2/en active IP Right Grant
- 2000-04-10 ES ES00915142T patent/ES2244417T3/es not_active Expired - Lifetime
- 2000-04-10 US US09/546,573 patent/US7108983B1/en not_active Expired - Fee Related
-
2001
- 2001-10-05 NO NO20014869A patent/NO329725B1/no not_active IP Right Cessation
-
2006
- 2006-06-09 US US11/449,869 patent/US7807379B2/en not_active Expired - Fee Related
-
2008
- 2008-04-11 US US12/101,661 patent/US20080261246A1/en not_active Abandoned
- 2008-08-07 US US12/187,939 patent/US20090035794A1/en not_active Abandoned
-
2010
- 2010-07-05 JP JP2010152840A patent/JP2010266455A/ja not_active Ceased
- 2010-08-30 US US12/871,735 patent/US20110060529A1/en not_active Abandoned
-
2011
- 2011-08-04 US US13/198,519 patent/US20110294148A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7108983B1 (en) | 2006-09-19 |
NO20014869D0 (no) | 2001-10-05 |
US20080261246A1 (en) | 2008-10-23 |
US20110294148A1 (en) | 2011-12-01 |
CA2366682A1 (en) | 2000-10-19 |
NO20014869L (no) | 2001-12-04 |
NZ515311A (en) | 2002-11-26 |
US20090035794A1 (en) | 2009-02-05 |
ATE298890T1 (de) | 2005-07-15 |
EP1619206A2 (de) | 2006-01-25 |
EP1171771B1 (de) | 2005-06-29 |
AU771309B2 (en) | 2004-03-18 |
US20110060529A1 (en) | 2011-03-10 |
EP1619206A3 (de) | 2006-02-15 |
ES2244417T3 (es) | 2005-12-16 |
JP2002541481A (ja) | 2002-12-03 |
US7807379B2 (en) | 2010-10-05 |
EP1171771A2 (de) | 2002-01-16 |
DE60021068T2 (de) | 2006-05-18 |
JP4638608B2 (ja) | 2011-02-23 |
WO2000062070A3 (en) | 2001-01-25 |
NO329725B1 (no) | 2010-12-06 |
CA2366682C (en) | 2009-06-23 |
JP2010266455A (ja) | 2010-11-25 |
AU3655600A (en) | 2000-11-14 |
US20070020707A1 (en) | 2007-01-25 |
WO2000062070A2 (en) | 2000-10-19 |
CA2652131A1 (en) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60021068D1 (de) | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker | |
AU3084802A (en) | Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes | |
NZ575886A (en) | Serine or cysteine proteinase inhibitor clade H (SERPHINH1) as a marker for detection of gastric cancer | |
GB2392978A (en) | Identification and use of conserved noncoding sequences | |
ATE283485T1 (de) | Verfahren zur diagnose und zur charakterisierung von schlaganfall | |
ATE412749T1 (de) | Chemisch modifizierter gewebeinhibitor für metalloproteasen type 3 (timp-3) | |
SG144729A1 (en) | Method for controlling the microbiological quality of an aqueous medium and kit therefor | |
ATE342918T1 (de) | Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma | |
ATE378404T1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
DE60117592T8 (de) | Diagnose von pre-eclampsia | |
FR2664702B1 (fr) | Procede de reduction d'interferences dans un dosage par fluorescence. | |
AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
DE60310012D1 (de) | Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer | |
ES2168816T3 (es) | Cemento de inyeccion que contiene inhibidores de la corrosion. | |
ATE412182T1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
WO2001090408A3 (fr) | Detection et caracterisation de l'activite de proteines impliquees dans la reparation de lesions de l'adn | |
WO2002044417A3 (en) | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2001063293A3 (en) | Diagnosis and treatment of schizophrenia | |
EP1141703A4 (de) | Verfahren zum bestimmen eines erhöhten risikos einer frau ein "down-syndrom" zu tragen | |
SI1664330T1 (sl) | Krvni in urinski preizkus | |
ATE321877T1 (de) | Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen | |
DE69939623D1 (de) | Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1) | |
GB2392911A (en) | Inhibitors of dna methyltransferase isoforms | |
EP1492880A4 (de) | Ex-vivo-verfahren zur bestimmung der cetp-aktivität und der wirksamkeit der behandlung von herzerkrankungen | |
ATE420361T1 (de) | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |